Is Establishment Labs Stock a Good Investment?
Establishment Labs Investment Advice | ESTA |
- Examine Establishment Labs' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Establishment Labs' leadership team and their track record. Good management can help Establishment Labs navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Establishment Labs' business and its evolving consumer preferences.
- Compare Establishment Labs' performance and market position to its competitors. Analyze how Establishment Labs is positioned in terms of product offerings, innovation, and market share.
- Check if Establishment Labs pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Establishment Labs' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Establishment Labs Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Establishment Labs Holdings is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Establishment Labs Stock
Researching Establishment Labs' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 89.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.0. Establishment Labs had not issued any dividends in recent years.
To determine if Establishment Labs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Establishment Labs' research are outlined below:
| Establishment Labs generated a negative expected return over the last 90 days | |
| Establishment Labs has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 166.03 M. Net Loss for the year was (84.6 M) with profit before overhead, payroll, taxes, and interest of 109.53 M. | |
| Establishment Labs Holdings currently holds about 65.35 M in cash with (58.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. | |
| Establishment Labs has a frail financial position based on the latest SEC disclosures | |
| Over 89.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: Establishment Labs Holdings Inc Trading Down 4.92 percent on Mar 26 |
Establishment Labs Quarterly Good Will |
|
Establishment Labs uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Establishment Labs Holdings. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Establishment Labs' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Establishment Labs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Establishment Labs' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-10 | 2020-12-31 | -0.19 | -0.23 | -0.04 | 21 | ||
2021-05-05 | 2021-03-31 | -0.34 | -0.29 | 0.05 | 14 | ||
2021-07-29 | 2021-06-30 | -0.28 | -0.22 | 0.06 | 21 | ||
2019-05-15 | 2019-03-31 | -0.46 | -0.53 | -0.07 | 15 | ||
2024-05-08 | 2024-03-31 | -0.67 | -0.58 | 0.09 | 13 | ||
2019-08-13 | 2019-06-30 | -0.53 | -0.44 | 0.09 | 16 | ||
2024-08-06 | 2024-06-30 | -0.51 | -0.62 | -0.11 | 21 | ||
2024-02-28 | 2023-12-31 | -0.91 | -0.79 | 0.12 | 13 |
Establishment Labs Target Price Consensus
Establishment target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Establishment Labs' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Establishment analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Establishment stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Establishment Labs, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationEstablishment Labs Target Price Projection
Establishment Labs' current and average target prices are 40.64 and 60.29, respectively. The current price of Establishment Labs is the price at which Establishment Labs Holdings is currently trading. On the other hand, Establishment Labs' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Establishment Labs Market Quote on 28th of March 2025
Target Price
Analyst Consensus On Establishment Labs Target Price
Establishment Labs Analyst Ratings
Establishment Labs' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Establishment Labs stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Establishment Labs' financials, market performance, and future outlook by experienced professionals. Establishment Labs' historical ratings below, therefore, can serve as a valuable tool for investors.Know Establishment Labs' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Establishment Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Establishment Labs Holdings backward and forwards among themselves. Establishment Labs' institutional investor refers to the entity that pools money to purchase Establishment Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bamco Inc | 2024-12-31 | 752.9 K | Millennium Management Llc | 2024-12-31 | 711.7 K | Balyasny Asset Management Llc | 2024-12-31 | 558.3 K | Jpmorgan Chase & Co | 2024-12-31 | 554.1 K | Polar Capital Holdings Plc | 2024-12-31 | 546.5 K | The Toronto-dominion Bank | 2024-12-31 | 540 K | Boothbay Fund Management, Llc | 2024-12-31 | 525.2 K | Mudita Advisors Llp | 2024-12-31 | 414.5 K | Ing Investment Management Llc | 2024-12-31 | 408.3 K | Jw Asset Management, Llc | 2024-12-31 | 3.1 M | Rtw Investments, Llc | 2024-12-31 | 2.6 M |
Establishment Labs' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.17 B.Market Cap |
|
Establishment Labs' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.27) | |
| Return On Capital Employed | (0.18) | (0.17) | |
| Return On Assets | (0.24) | (0.26) | |
| Return On Equity | (1.59) | (1.51) |
Determining Establishment Labs' profitability involves analyzing its financial statements and using various financial metrics to determine if Establishment Labs is a good buy. For example, gross profit margin measures Establishment Labs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Establishment Labs' profitability and make more informed investment decisions.
Establishment Labs' Earnings Breakdown by Geography
Please note, the presentation of Establishment Labs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Establishment Labs' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Establishment Labs' management manipulating its earnings.
Evaluate Establishment Labs' management efficiency
Establishment Labs has return on total asset (ROA) of (0.1015) % which means that it has lost $0.1015 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.3666) %, meaning that it created substantial loss on money invested by shareholders. Establishment Labs' management efficiency ratios could be used to measure how well Establishment Labs manages its routine affairs as well as how well it operates its assets and liabilities. As of March 28, 2025, Return On Tangible Assets is expected to decline to -0.27. The current year's Return On Capital Employed is expected to grow to -0.17. At present, Establishment Labs' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 7.7 M, whereas Total Assets are forecasted to decline to about 176.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.90 | 1.05 | |
| Tangible Book Value Per Share | 1.44 | 0.86 | |
| Enterprise Value Over EBITDA | (21.33) | (22.40) | |
| Price Book Value Ratio | 24.21 | 25.42 | |
| Enterprise Value Multiple | (21.33) | (22.40) | |
| Price Fair Value | 24.21 | 25.42 | |
| Enterprise Value | 1.2 B | 760.6 M |
Understanding the operational decisions made by Establishment Labs management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 0.951 |
Basic technical analysis of Establishment Stock
As of the 28th of March, Establishment Labs shows the Coefficient Of Variation of 2437.21, mean deviation of 3.66, and Downside Deviation of 6.51. Establishment Labs technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Establishment Labs' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Establishment Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on Establishment Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Establishment Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Establishment Labs' Outstanding Corporate Bonds
Establishment Labs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Establishment Labs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Establishment bonds can be classified according to their maturity, which is the date when Establishment Labs Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Establishment Labs' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Establishment Labs' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0427 | |||
| Market Risk Adjusted Performance | 0.1513 | |||
| Mean Deviation | 3.66 | |||
| Semi Deviation | 6.17 | |||
| Downside Deviation | 6.51 | |||
| Coefficient Of Variation | 2437.21 | |||
| Standard Deviation | 5.69 | |||
| Variance | 32.33 | |||
| Information Ratio | 0.0438 | |||
| Jensen Alpha | 0.2641 | |||
| Total Risk Alpha | 0.3994 | |||
| Sortino Ratio | 0.0383 | |||
| Treynor Ratio | 0.1413 | |||
| Maximum Drawdown | 31.96 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 7.41 | |||
| Downside Variance | 42.39 | |||
| Semi Variance | 38.05 | |||
| Expected Short fall | (3.59) | |||
| Skewness | (1.18) | |||
| Kurtosis | 7.61 |
| Risk Adjusted Performance | 0.0427 | |||
| Market Risk Adjusted Performance | 0.1513 | |||
| Mean Deviation | 3.66 | |||
| Semi Deviation | 6.17 | |||
| Downside Deviation | 6.51 | |||
| Coefficient Of Variation | 2437.21 | |||
| Standard Deviation | 5.69 | |||
| Variance | 32.33 | |||
| Information Ratio | 0.0438 | |||
| Jensen Alpha | 0.2641 | |||
| Total Risk Alpha | 0.3994 | |||
| Sortino Ratio | 0.0383 | |||
| Treynor Ratio | 0.1413 | |||
| Maximum Drawdown | 31.96 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 7.41 | |||
| Downside Variance | 42.39 | |||
| Semi Variance | 38.05 | |||
| Expected Short fall | (3.59) | |||
| Skewness | (1.18) | |||
| Kurtosis | 7.61 |
Consider Establishment Labs' intraday indicators
Establishment Labs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Establishment Labs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Establishment Labs Corporate Filings
F4 | 26th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
8K | 26th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of February 2025 Other Reports | ViewVerify |
Establishment Stock media impact
Far too much social signal, news, headlines, and media speculation about Establishment Labs that are available to investors today. That information is available publicly through Establishment media outlets and privately through word of mouth or via Establishment internal channels. However, regardless of the origin, that massive amount of Establishment data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Establishment Labs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Establishment Labs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Establishment Labs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Establishment Labs alpha.
Establishment Labs Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Establishment Labs can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Establishment Labs Maximum Pain Price Across May 16th 2025 Option Contracts
Establishment Labs' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Establishment Labs close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Establishment Labs' options.
Establishment Labs Corporate Management
| Heather Brennan | Head Operations | Profile | |
| Roberto Mezerville | Chief Officer | Profile | |
| Paul Rodio | Chief Officer | Profile | |
| Jeff Ehrhard | Senior America | Profile | |
| Jeff Ehrhardt | Senior America | Profile | |
| Ivan Bilic | Senior OUS | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Revenue Per Share | Quarterly Revenue Growth 0.41 | Return On Assets | Return On Equity |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Establishment Labs' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.